Committed to sharing our science

Committed to sharing our science

327 results available

A First-in-Human, Single and Multiple Ascending Dose Study of CK-4021586, a Novel Cardiac Myosin Inhibitor

Poster, American College of Clinical Pharmacology 2024

Lutz JD, et al

September 8, 2024
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial

Journal of the American Medical Association – Cardiology

Lee, M et al

September 4, 2024
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology

Hegde, S et al

September 1, 2024
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy

Journal of the American College of Cardiology

Masri, A et al

September 1, 2024
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Journal of the American College of Cardiology

Sherrod, S et al

September 1, 2024